Mes-Masson, who directs several oncology research programs, has conducted research that has enhanced our knowledge in the field of ovarian cancer and has made discoveries that have contributed to the development of new clinical tools to diagnose, manage and treat this deadly disease. Being elected to the Royal Society of Canada is the greatest honour that can be granted to an academic working in the field of the arts, humanities and sciences.